Author/Authors :
Sitar، Gungor نويسنده Okmeydani Research and Educational Hospital, Istanbul, Turkey , , Kucuk، Mehmet نويسنده Okmeydani Research and Educational Hospital, Istanbul, Turkey , , Erinc Sitar، Mustafa نويسنده Department of Clinical Biochemistry, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey , , Yasar، Ozgur نويسنده Department of Clinical Biochemistry, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey , , Aydin، Seval نويسنده Department of Clinical Biochemistry, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey , , Yanar، Karolin نويسنده Department of Clinical Biochemistry, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey , , Cakatay، Ufuk نويسنده Department of Clinical Biochemistry, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey , , Buyukpınarbasili، Nur نويسنده Department of Pathology, Faculty of Medicine, Istanbul Bezmialem Vakif University, Istanbul, Turkey ,
Abstract :
One of the most important side effects of contrast pharmaceutical agents, which are used very common in routine radiology practice, is contrast induced nephropathy. Even ischemia, oxidative stress and osmolality related cytotoxic effects are considered, the molecular mechanisms underlying this pathology have not been identified completely yet. The aim of the current study was to reveal the role of oxidative stress and antioxidant enzymatic defence mechanisms in the aetiopathogenesis of contrast-induced nephropathy. We also studied possible alleviating effects of N-acetylcysteine (NAC), a potent antioxidant, to obtain extra information regarding the molecular mechanisms underlying this pathology. This is an clinical-experimental study, This study was conducted of Istanbul/Turkey between September 15, 2012 and April 15, 2013. Three groups of male rats were randomly set up as a control group (C), a 100 mg/kg intraperitoneal NAC + 7 mL/kg contrast agent group (N + CIN) and a 7 mL/kg intraperitoneal contrast agent group (CIN). They were placed in individual metabolic cages 48 hours after agent administration to obtain 24-hour urine samples. Renal function tests (albumin, urea, creatinine, total protein) were conducted, oxidative stress parameters (Cu, Zn superoxide dismutase activity - Cu, Zn-SOD; advanced oxidation protein products - AOPP; protein carbonyls - PCO; total thiol groups - T-SH; and lipid hydroperoxides -LHP) were measured and tissues were analysed histopathologically. Compared with the control group, groups CIN and N + CIN had significantly higher urea and LHP levels (P < 0.05 and P < 0.001, respectively) and significantly lower Cu, Zn-SOD activity and creatinine clearance (P < 0.05). There was no statistically significant difference between the groups in PCO or AOPP levels despite differences in descriptive statistics. Contrast-agent-induced nephropathic changes are more closely related to the magnitude of lipid peroxidation than protein oxidation.
